Brief: Biohit Publishes Results From Comparison Study With ColonView-FIT
Jan 18 (Reuters) - Biohit Oyj BIOBV.HE :
* BIOHIT NEW-GENERATION FECAL IMMUNOCHEMICAL TEST
(COLONVIEW-FIT)
IS SUPERIOR TO TRADITIONAL GUAIAC TEST IN COLORECTAL CANCER
SCREENING
* COLONVIEW-FIT SHOWED A SENSITIVITY FAR SUPERIOR TO
COMPARISON
TEST IN DETECTING FOB IN PATIENTS REFERRED FOR COLONOSCOPY
Source text for Eikon: ID:nGNEc77nqm
Further company coverage: BIOBV.HE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))